Resources from the same session
1022MO - Clinical potential of adoptive cell therapy with tumour infiltrating lymphocytes therapy in combination with checkpoint inhibitors in non-melanoma patients
Presenter: Anders Kverneland
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1027MO - ALKS 4230 monotherapy and in combination with pembrolizumab (pembro) in patients (pts) with refractory solid tumours (ARTISTRY-1)
Presenter: Ulka Vaishampayan
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
LBA42 - POD1UM-202: Phase II study of retifanlimab in patients (pts) with squamous carcinoma of the anal canal (SCAC) who progressed following platinum-based chemotherapy
Presenter: Sheela Rao
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1023MO - AMC 095: A report of nivolumab (nivo) in advanced HIV associated solid tumours (ST)
Presenter: Lakshmi Rajdev
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1024MO - A phase I/II MATINS trial: Part 1 pharmacokinetic, safety and efficacy results of Clever-1 blockade in advanced cancer
Presenter: Petri Bono
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1025MO - First-in-human (FIH) phase I study of RO7122290 (RO), a novel FAP-targeted 4-1BB agonist, administered as single agent and in combination with atezolizumab (ATZ) to patients with advanced solid tumours
Presenter: Ignacio Melero
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1026MO - Phase Ib dose escalation study of novel immunogenic cell death (ICD) inducer PT-112 plus PD-L1 inhibitor avelumab in solid tumours
Presenter: Daniel Karp
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Invited Discussant 1022MO and 1027MO
Presenter: Fiona Thistlethwaite
Session: Mini Oral - Investigational immunotherapy
Resources:
Slides
Webcast
Invited Discussant LBA42 and 1023MO
Presenter: Inge-Marie Svane
Session: Mini Oral - Investigational immunotherapy
Resources:
Slides
Webcast
Invited Discussant 1024MO, 1025MO and 1026MO
Presenter: Pedro Romero
Session: Mini Oral - Investigational immunotherapy
Resources:
Slides
Webcast